Specific immunotherapy for the prevention of diabetes: theoretical and practical aspects.
Vialettes
B
B
Laboratory of Diabetology, University of Marseille, France.
Atlan-Gepner
C
C
Hermitte
L
L
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000502:physiology; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000502:physiology; D008297:Male; D051379:Mice; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology
D007376:Interleukin-2; D008222:Lymphokines